文献速递临床试验与 GCP流行病学与生物统计

临床试验参与者的不当负担:对公平性、多样性和包容性的影响

The undue burdens of clinical trial participation: implications for equity, diversity, and inclusion.
PubMed 文献 · Trials · 2026-02-07

本文聚焦临床试验中参与者负担过重对公平性、多样性和包容性的影响,指出数据收集量过大且部分数据与主要目标无关或从未分析,导致某些群体被系统性排除;尽管以参与者为中心的试验方法日益受重视,但试验复杂性和数据量仍在持续上升,作者呼吁将减少不必要负担视为所有临床试验设计的道德义务。

要点

  • 参与者负担包括旅行、时间投入、心理或后勤挑战,以及数据收集量过大。
  • 负担过重对少数族裔、有照护责任者和老年人等群体造成不成比例的影响。
  • 以参与者为中心的理念与当前试验实践之间的差距扩大,需要转变方法。

核心结论

  • 减少不必要的参与者负担应被视为所有临床试验设计中的道德义务,以避免某些群体被系统性排除。

研究设计与样本

  • 本文为聚焦数据相关方面的论述性文章,探讨不当负担的伦理影响并提出减轻负担的措施。

主要发现

  • 参与者负担可包括与试验干预相关的潜在身体负担,以及与旅行、时间投入、心理或后勤挑战相关的繁重要求。
  • 许多负担因素已被证明会造成障碍,对少数族裔群体、有照护责任者和老年人等特定群体产生不成比例的影响。
  • 参与者负担中一个日益严重的问题是数据收集量过大,其中许多数据可能与研究主要目标缺乏直接相关性且可能从未被分析。
  • 尽管以实用和参与者为中心的试验方法在过去十年中日益突出,但定量证据表明试验复杂性和数据量仍在持续上升。

临床怎么用

  • 作者认为减少不必要的负担应被视为所有临床试验设计中的道德义务,以避免某些群体被系统性排除。
  • 作者提出措施以帮助最小化和减轻参与者负担,从而促进临床研究的包容性和代表性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A wide range of factors has detrimental impacts upon equity, diversity, and inclusion in clinical trials, amongst which participant burden can be significant. In addition to the potential physical burdens associated with investigational interventions, participants may face onerous demands related to factors like travel, time commitments, psychological, or logistical challenges. Many of these factors have been shown to create barriers that disproportionately affect certain groups like minoritised ethnic groups, people with caring responsibilities, and older adults. One increasingly problematic aspect of participant burden is associated with an excessive volume of data collection, much of which may lack direct relevance to the study's primary objectives and may never be analysed. Although pragmatic and participant-centred trial methodologies have risen in prominence over the past decade, quantitative evidence demonstrates that trial complexity and data volumes are continuing to rise. The widening gap between the notion of participant-centricity and the realities of current trial practice underscores the need for a shift in approach. Reducing unnecessary burden should be regarded as a moral obligation across all clinical trial designs to avoid the systematic exclusion of certain groups. With a focus on data-related aspects, this paper examines the ethical implications of undue burdens upon participants and proposes measures to help minimise and mitigate these burdens. In addressing this issue, researchers contribute to broader efforts to enhance inclusivity and representation in clinical studies.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Law E, Chatfield K. The undue burdens of clinical trial participation: implications for equity, diversity, and inclusion. Trials. 2026. PMID: 41654869. doi:10.1186/s13063-026-09540-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。